ATE212056T1 - Methoden zur herstellung von rna viren aus cdna - Google Patents

Methoden zur herstellung von rna viren aus cdna

Info

Publication number
ATE212056T1
ATE212056T1 AT91916420T AT91916420T ATE212056T1 AT E212056 T1 ATE212056 T1 AT E212056T1 AT 91916420 T AT91916420 T AT 91916420T AT 91916420 T AT91916420 T AT 91916420T AT E212056 T1 ATE212056 T1 AT E212056T1
Authority
AT
Austria
Prior art keywords
methods
cdna
rna virus
rna viruses
producing
Prior art date
Application number
AT91916420T
Other languages
English (en)
Inventor
Vincent Racaniello
Joanne Marie Tatem
Carolyn L Weeks-Levy
Original Assignee
Univ Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Columbia filed Critical Univ Columbia
Application granted granted Critical
Publication of ATE212056T1 publication Critical patent/ATE212056T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT91916420T 1990-08-20 1991-08-20 Methoden zur herstellung von rna viren aus cdna ATE212056T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US57000090A 1990-08-20 1990-08-20
US56991690A 1990-08-20 1990-08-20
PCT/US1991/005890 WO1992003538A1 (en) 1990-08-20 1991-08-20 METHODS FOR PRODUCING RNA VIRUSES FROM cDNA

Publications (1)

Publication Number Publication Date
ATE212056T1 true ATE212056T1 (de) 2002-02-15

Family

ID=27075179

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91916420T ATE212056T1 (de) 1990-08-20 1991-08-20 Methoden zur herstellung von rna viren aus cdna

Country Status (12)

Country Link
US (5) US5525715A (de)
EP (1) EP0496875B1 (de)
JP (1) JPH05503634A (de)
KR (1) KR100230195B1 (de)
AT (1) ATE212056T1 (de)
AU (1) AU656328B2 (de)
CA (1) CA2067337A1 (de)
DE (1) DE69132900D1 (de)
IL (1) IL99232A0 (de)
NO (1) NO303943B1 (de)
PT (1) PT98725B (de)
WO (1) WO1992003538A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0563487A1 (de) * 1992-03-31 1993-10-06 Laboratoire Europeen De Biotechnologie S.A. Monoklonale Antikörper gegen den Interferonrezeptor, mit neutralisierender Aktivität gegen Typ I-Interferon
EP0660258B1 (de) * 1993-12-20 2000-03-08 Seiko Epson Corporation Elektronische Hinweisanordnung
US6071745A (en) * 1997-06-27 2000-06-06 Bio-Rad Laboratories Method and formulation for lyophilizing cultured human cells to preserve RNA and DNA contained in cells for use in molecular biology experiments
US6846655B1 (en) * 1998-06-29 2005-01-25 Phylos, Inc. Methods for generating highly diverse libraries
WO2001078789A2 (en) 2000-04-14 2001-10-25 The Uab Research Foundation Poliovirus replicons encoding therapeutic agents and uses thereof
US20030092035A1 (en) * 2000-05-04 2003-05-15 Anderson David J. Pain signaling molecules
AU2002306709A1 (en) * 2001-03-14 2002-09-24 Replicon Technologies, Inc. Oncolytic rna replicons
WO2016201224A1 (en) * 2015-06-10 2016-12-15 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Processes for production and purification of nucleic acid-containing compositions
EP3569618A1 (de) 2018-05-19 2019-11-20 Boehringer Ingelheim International GmbH Antagonisierender cd73-antikörper
CN119350457B (zh) * 2024-11-28 2025-04-25 国药中生生物技术研究院有限公司 一种脊髓灰质炎疫苗及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4719177A (en) * 1981-04-20 1988-01-12 Massachusetts Institute Of Technology Production of complementary DNA representing RNA viral sequences by recombinant DNA methods and uses therefor

Also Published As

Publication number Publication date
US5834302A (en) 1998-11-10
WO1992003538A1 (en) 1992-03-05
EP0496875A4 (en) 1993-12-29
PT98725A (pt) 1992-07-31
AU8533391A (en) 1992-03-17
NO921472L (no) 1992-04-13
JPH05503634A (ja) 1993-06-17
CA2067337A1 (en) 1992-02-21
NO303943B1 (no) 1998-09-28
KR920702411A (ko) 1992-09-04
DE69132900D1 (de) 2002-02-21
US6136570A (en) 2000-10-24
AU656328B2 (en) 1995-02-02
IL99232A0 (en) 1992-07-15
EP0496875A1 (de) 1992-08-05
PT98725B (pt) 1999-01-29
EP0496875B1 (de) 2002-01-16
KR100230195B1 (ko) 1999-11-15
US5683901A (en) 1997-11-04
US5525715A (en) 1996-06-11
US5580719A (en) 1996-12-03
NO921472D0 (no) 1992-04-13

Similar Documents

Publication Publication Date Title
DK0690675T5 (da) Nukleinsyre, der koder for en tumorafstödningsantigenprecursor
ATE253637T1 (de) Methoden zur erhöhung der biologischen aktivität von chemokinen
ES487106A0 (es) Un metodo para producir al menos un polipeptido que muestra antigenicidad de hbv
DK0702085T3 (da) Rekombinant infektiøs ikke-segmenteret negativ-strenget RNA-virus
DE69106815D1 (de) Verfahren zur Herstellung von veränderten Kohlenstoffmolekularsieben zur Gastrennung.
DE69521521D1 (de) Mono- oder polyfunktionelle konjugate von polylysine
DE69132900D1 (de) Methoden zur herstellung von rna viren aus cdna
PT84155A (en) Method of modifying plant viruses or their effects
DE69028951D1 (de) Oligonukleotiden-Sequenzen zur Amplifizierung von HIV-2 und SIV Retrovirusgenomen, ihre Verwendung zur In-vitro-Diagnostik von durch diese Viren verursachten Infektionen
NO923918D0 (no) Nye t-celle-lymfom cdna-kloner
ATE120494T1 (de) Fibronectinbindungsprotein und dessen herstellung.
EE04379B1 (et) Meetod viirusresistentsuse tekitamiseks taimes
ATE121779T1 (de) Nichtzurückschlagende rns-viren.
DE69528578D1 (de) Verändertes l2-protein des papillomavirus und damit gestellte viroide
ATE114478T1 (de) Verfahren zur kontrolle der leukozyten- extravasation.
ATE190492T1 (de) Verwendung von gift aus hautflüglern (hymenopteren) zur herstellung eines medikamentes zur behandlung von infektionen durch dna-viren
ATE132527T1 (de) Nicht-zurückmutierende rna-viren
ATE55257T1 (de) Verfahren zur herstellung von hochgereinigten, hepatitis-b-virus-infektionsfreien gammaglobulinen.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties